Fiocruz

Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Simplified molecular diagnosis for leishmaniasis

Innovation Portfolio
Simplified molecular diagnosis for leishmaniasis
Download as PDF: | Share:

Problem

Leishmaniasis is a global public health problem and presents symptoms similar to other diseases which makes it essential to confirm suspected cases through laboratory diagnosis. Molecular diagnosis based on the polymerase chain reaction (PCR) technique is highly accurate. However, its use is restricted to reference laboratories due to the need for a complex laboratory infrastructure and qualified professionals. 

 

Solution

The proposed technology consists of the creation of a new set of primers and method for the Loop-mediated Isothermal Amplification (LAMP) assay to quickly and accurately detect and identify Leishmania DNA in biological samples from human patients with visceral leishmaniasis. and integumentary, and in dogs with visceral leishmaniasis. As it is easy to perform and interpret, the test can be carried out in laboratories with less complexity by local professionals, and in basic health units.

Differential


gps_fixed
High accuracy
navigation
Simple execution
trending_down
Cost reduction

Development stage


What we are searching for

Co-development or technology licensing agreement. 

Inventors

Daniel Moreira de Avelar
Arthur Ribeiro Cheloni Soares
Verônica Cardoso Santos de Faria

Intellectual Property

Type
Invention Patent
Description
Patent application filed in Brazil, China and India

 

 

 

Use your phone camera to scan the QR Code:

 

Campus Fiocruz Maré - Av. Brasil, 4036 - Maré, Rio de Janeiro - RJ

CEP: 21040-361

     
  portfolio@fiocruz.br 
     
  +55 (21) 3282-9080 

 

   
   
   

 

Back to the topBack